Bank of New York Mellon Corp - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$25,679
-22.3%
29,5190.0%0.00%
Q2 2023$33,061
+7.7%
29,5190.0%0.00%
Q1 2023$30,700
-7.1%
29,5190.0%0.00%
Q4 2022$33,061
+0.2%
29,5190.0%0.00%
Q3 2022$33,000
-23.3%
29,5190.0%0.00%
Q2 2022$43,000
-39.4%
29,519
-4.1%
0.00%
Q1 2022$71,000
-16.5%
30,7950.0%0.00%
Q4 2021$85,000
-54.1%
30,7950.0%0.00%
Q3 2021$185,000
+98.9%
30,795
+61.2%
0.00%
Q2 2021$93,000
+97.9%
19,1030.0%0.00%
Q1 2021$47,000
-19.0%
19,103
-9.1%
0.00%
Q4 2020$58,000
+81.2%
21,0090.0%0.00%
Q3 2020$32,000
-17.9%
21,0090.0%0.00%
Q2 2020$39,000
+8.3%
21,0090.0%0.00%
Q1 2020$36,000
-41.0%
21,0090.0%0.00%
Q4 2019$61,000
+369.2%
21,0090.0%0.00%
Q3 2019$13,000
-72.3%
21,009
-56.5%
0.00%
Q2 2019$47,000
-69.1%
48,243
-56.3%
0.00%
Q1 2019$152,000
+26.7%
110,300
-1.5%
0.00%
Q4 2018$120,000
-76.9%
111,970
+32.8%
0.00%
Q3 2018$519,000
-39.7%
84,318
+4.7%
0.00%
Q2 2018$861,000
-46.1%
80,520
-45.9%
0.00%
Q1 2018$1,597,000
+151.1%
148,796
+64.0%
0.00%
Q4 2017$636,000
-20.0%
90,721
-0.3%
0.00%
Q3 2017$795,000
-6.7%
91,007
-2.7%
0.00%
Q2 2017$852,000
+207.6%
93,500
+168.5%
0.00%
Q1 2017$277,000
-1.4%
34,823
+10.8%
0.00%
Q4 2016$281,000
-2.8%
31,419
+88.2%
0.00%
Q3 2016$289,00016,6980.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders